Ultrasound-induced Adipose Tissue Cavitation and Training in Obesity

NCT04417816 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2021-08-27

No results posted yet for this study

Summary

The addition of ultrasound-induced adipose tissue cavitation (UATC) at the level of the abdominal subcutaneous adipose tissue may seem relevant as an additive treatment option to exercise intervention in individuals with obesity. However, whether individuals with obesity who participate in an exercise intervention and additionally undergo UATC, are more likely to develop a metabolically healthy phenotype, as opposed to subjects with obesity undergoing exercise training or UATC only, remains to be studied. Therefore, the first aim of this study is to examine the impact of combined UATC during exercise intervention on abdominal subcutaneous and whole-body adipose tissue mass, quality of life and cardiometabolic risk in individuals with abdominal obesity.

Conditions

Interventions

OTHER

Exercise training intervention with ultrasound induced adipose tissue cavitation

Exercise training intervention with ultrasound induced adipose tissue cavitation

OTHER

Exercise training intervention without ultrasound induced adipose tissue cavitation

Exercise training intervention with ultrasound induced adipose tissue cavitation

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Principal Investigators

  • Dominique Hansen, prof. dr. · Hasselt University

  • Kenneth Verboven, dr. · Hasselt University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-15
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04417816 on ClinicalTrials.gov